Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab
- Resource Type
- Article
- Source
- In
Clinical Gastroenterology and Hepatology October 2023 21(11):2908-2917 - Subject
- Language
- ISSN
- 1542-3565